In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alvogen Korea

Division of Alvogen Inc.
www.kunwha.com

Latest From Alvogen Korea

Contrave Launch Raises Hopes For Korean Obesity Market Growth

Following the successful debut of Arena's Belviq in 2015, Orexigen's Contrave, which will be released in South Korea in the second quarter through its partner Kwang Dong Pharm, is set to boost the domestic obesity treatment market which had been depressed since the country banned sales of sibutramine-based drugs in 2010.

BioPharmaceutical Asia Pacific

Deals Shaping The Medical Industry, July 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2015.

BioPharmaceutical Medical Device

Korea’s LG Life Sciences And Japan’s Mochida Cut Biosimilar Deal

LG Life Sciences ramps up its biosimilars development in Korea and Japan through deal with Japan’s Mochida that covers development and commercialization activities.

BioPharmaceutical Japan

Teva Rumored To Be In M&A Talks With Mid-sized Korean Pharma

Predictions of heightened M&A activity among smaller South Korean generic drug firms gained firmer ground this week after an offhand comment by a government official pointed to interest by Teva in a mid-tier firm.

BioPharmaceutical Asia Pacific
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Kunwha Pharmaceutical Co. Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • Alvogen Inc.
  • Senior Management
  • Lee Joo Hyung, EVP
  • Contact Info
  • Alvogen Korea
    Phone: (82) 2-2047-7700
    10, Gukjegeumyung-ro, Yeongdeungpo-gu
    Seoul,
    South Korea
Advertisement
Advertisement
UsernamePublicRestriction

Register